XOMA (XOMAP) Stock Price, News & Analysis

Company Overview

XOMA Corporation (NASDAQ:XOMAP) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and delivering therapeutic antibodies for the treatment of inflammatory and autoimmune diseases. The company leverages its proprietary protein engineering and antibody discovery platforms to create novel biologic candidates designed to modulate key immune pathways. XOMA’s research focuses on targets implicated in conditions such as systemic lupus erythematosus, rheumatoid arthritis and other chronic inflammatory disorders.

XOMA’s pipeline includes multiple antibody candidates at various stages of development, ranging from lead optimization to early clinical trials. The company employs structure‐guided design and high‐throughput screening to enhance the specificity and potency of its product candidates. XOMA also pursues strategic partnerships to co‐develop assets and expand its reach into new therapeutic areas, collaborating with academic institutions and industry leaders to accelerate progress from preclinical discovery to human studies.

Founded in 1981 and headquartered in Berkeley, California, XOMA has driven innovation in protein therapeutics for more than three decades. The company operates research facilities in the San Francisco Bay Area and maintains relationships with contract development and manufacturing organizations worldwide. Under the leadership of President and Chief Executive Officer Paul Rubin, XOMA continues to build on its legacy of antibody discovery, with a focus on bringing first‐in‐class and best‐in‐class therapies to patients in need of novel treatments for immune‐mediated diseases.

Key Stats

• Today's Range: $25.71 to $25.87
• 50-Day Range: $25.44 to $26.07
• 52-Week Range: $24.96 to $26.51
• Volume: 588 shs
• Average Volume: 1,571 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 8.35%
• Price Target: N/A
• Consensus Rating: N/A

XOMAP Stock Analysis - Frequently Asked Questions

How have XOMAP shares performed this year?

XOMA's stock was trading at $25.88 on January 1st, 2025. Since then, XOMAP shares have decreased by 0.0% and is now trading at $25.87.

How do I buy shares of XOMA?

Shares of XOMAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 7/15 Dividend: 7/03/2025
• Ex-Dividend for 7/15 Dividend: 7/03/2025
• Dividend Payable: 7/15/2025
• Today: 8/09/2025
• Next Earnings (Estimated): 8/11/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:XOMAP
• CIK: 791908
• Web: www.xoma.com
• Phone: 510-204-7200
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $13.05 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A